my.jhsph.eduBloomberg School of Public Health HomeDEPARTMENTSACADEMICSRESOURCESRESEARCH & CENTERSADMISSIONS
Public Health News
NEWS CENTER

Home

Terrorism and Public Health Preparedness

News Archives

SUBSCRIPTIONS

RSS/Podcasts 
Magazine 
Email Updates
 
Media Archive

MEDIA INQUIRIES

Media Services

410-955-6878

paffairs@jhsph.edu

HIGHLIGHTS

School at a Glance 

Dean's Letter

Accreditation

Scholars

Lectureships

Student Webpages

Honors & Awards

PUBLICATIONS

Saving Lives Millions at a Time

Johns Hopkins Public Health Magazine



View Contents

Johns Hopkins Public Health Magazine

View Contents

View Contents



Learn About Our Global Projects
Learn About Our Global Projects

Learn About Our Global Projects



 email to a colleague | support our research 

September 5, 2003

School of Public Health Part of Regional Biodefense Center

The Johns Hopkins Bloomberg School of Public Health is one of 16 biomedical research institutions that will form the new Middle Atlantic Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE), established by the National Institute of Allergy and Infectious Diseases (NIAID). On Thursday, the University of Maryland School of Medicine announced it was awarded a five-year $42 million grant from NIAID to lead the Middle Atlantic RCE, which will work to develop new and improved vaccines, diagnostic tools and treatments for potential biological agents and infectious diseases. Some of the proposed projects include developing new vaccines against the anthrax bacillus and the smallpox, Ebola and West Nile viruses.

Myron M. Levine, MD, DTPH, director of the Center for Vaccine Development at the University of Maryland School of Medicine, is principal investigator for the Middle Atlantic RCE. More than 60 scientists will be participating as investigators and co-investigators of research projects.

"This network represents an unprecedented use of medical research capabilities to combat terrorism," said Donald Burke, MD, director of the Center for Immunization Research at the School of Public Health, and RCE co-principal investigator. Along with Dr. Levine, Dr. Burke will serve as part of a five-member executive committee, which will provide senior coordination of the RCE.

In addition to the University of Maryland and Johns Hopkins, the RCE also includes the University of Pennsylvania, University of Virginia, Uniformed Services University of the Health Sciences, Virginia Polytechnic Institute and State University, Virginia Bioinformatics Institute, University of Pittsburgh, George Washington University, Georgetown University, West Virginia University, Drexel University, University of Vermont, University of Missouri, Kansas City, University of Maryland Biotechnology Institute and Virginia Commonwealth University.

The Middle Atlantic RCE is one of eight to be established nationwide with grants totaling approximately $350 million over the next five years. Each center is composed of a lead institution and affiliated institutions located primarily in the same geographical region.

University of Maryland News Release

NIAID News Release

Public Affairs Media Contacts for the Johns Hopkins Bloomberg School of Public Health: Tim Parsons or Kenna Brigham at 410-955-6878 or paffairs@jhsph.edu. Photographs of Donald Burke are available upon request.

TOOLS

Contact JHSPH
Feedback
Email this Page
Course Search
Faculty Directory
Find an Expert
CoursePlus

Make a Gift

SEARCH
LEARN MORE ABOUT
Malaria

Online: "Progress Against Malaria"

"Breaking the Cycle" Special Report

Malaria Research Institute

Pandemic Flu

Pandemic Flu Guide for Individuals and Families

FAQ

Water

The Future of Drinking Water: Making it Safe

Email Hoax About Freezing Water Bottles



Johns Hopkins University

  © 2008, Johns Hopkins University. All rights reserved.
 Web policies, 615 N. Wolfe Street, Baltimore, MD 21205, 410-955-6878